SINGAPORE GENERAL HOSPITAL

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Established: 1821-01-01

Employees: -

Market Cap: -

Website: http://www.sgh.com.sg/Pages/default.aspx

Clinical Trials

Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases

Recruiting

Conditions: Diffuse Parenchymal Lung Diseases

First Posted Date: 2012-05-17

Last Posted Date: 2024-04-19

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 500

Registration Number: NCT01600378

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

Completed

Conditions: Interstitial Lung Disease

First Posted Date: 2012-05-17

Last Posted Date: 2017-11-08

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 20

Registration Number: NCT01600352

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Database of All Patients Who Have Undergone Pulmonary Function Testing at Singapore General Hospital

Completed

Conditions: Dyspnea
Restrictive Lung Disease
Cough
Obstructive Pulmonary Diseases

First Posted Date: 2012-05-17

Last Posted Date: 2019-05-15

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 17000

Registration Number: NCT01601288

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection

Completed

Conditions: Tuberculosis

First Posted Date: 2012-05-17

Last Posted Date: 2019-05-15

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 4600

Registration Number: NCT01601275

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Prospective Randomized Trial Comparing DEB Versus Conventional PTA for the Treatment of Hemodialysis AVF or AVG Stenoses

Not Applicable

Completed

Conditions: Arteriovenous Graft Stenosis
Stenosis of Arteriovenous Dialysis Fistula

Interventions: Device: Drug Eluting Balloon (DEB)
Device: Conventional PTA

First Posted Date: 2012-03-06

Last Posted Date: 2017-11-06

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 125

Registration Number: NCT01544907

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Knee Articular Cartilage Repair: Cartilage Autograft Implantation System Versus Conventional Microfracture

Phase 3

Conditions: Other Articular Cartilage Disorders
Osteochondritis Dissecans

Interventions: Procedure: Microfracture
Device: Cartilage Autograft Implantation System (CAIS)

First Posted Date: 2011-12-23

Last Posted Date: 2012-03-21

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 36

Registration Number: NCT01498029

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications

Completed

Conditions: Respiratory Tract Infections
Lung Diseases, Interstitial
Pleural Effusions
Lung Neoplasm

Interventions: Procedure: Respiratory endoscopy

First Posted Date: 2011-06-16

Last Posted Date: 2021-10-01

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 4000

Registration Number: NCT01374542

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients

Phase 2

Terminated

Conditions: Myelodysplastic Syndrome

Interventions: Drug: Decitabine

First Posted Date: 2011-04-12

Last Posted Date: 2014-06-17

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 6

Registration Number: NCT01333449

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

Phase 2

Completed

Conditions: Knee Osteoarthritis

Interventions: Drug: Control
Drug: Etoricoxib

First Posted Date: 2010-11-23

Last Posted Date: 2017-02-10

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 65

Registration Number: NCT01246362

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma

Phase 1

Completed

Conditions: Diffuse Large B-Cell Lymphoma

Interventions: Drug: bortezomib, rituximab, ifosphamide, etoposide, carboplatin

First Posted Date: 2010-10-22

Last Posted Date: 2017-04-27

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 6

Registration Number: NCT01226849

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy